Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells

Jiahe Lu1,2, Alisa Veler1, Boris Simonetti3

  • 1School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.

Cells
|November 10, 2023
PubMed

Insights

T cells express multiple inhibitory receptors like CTLA-4, PD-1, LAG3, TIM3, and TIGIT. Their distinct subcellular distributions are driven by unique trafficking pathways, crucial for cancer immunotherapy targets.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • T cells express multiple inhibitory receptors, including CTLA-4, PD-1, LAG3, TIM3, and TIGIT.
  • These receptors are critical therapeutic targets in cancer immunotherapy, particularly in anti-tumor responses.
  • The subcellular localization and trafficking of these receptors remain incompletely understood.

Purpose of the Study:

  • To investigate the distinct subcellular distributions of five key inhibitory T cell receptors.
  • To elucidate the trafficking mechanisms that drive these divergent distributions.
  • To provide a foundation for therapeutic exploitation of inhibitory receptor trafficking.

Main Methods:

  • Quantitative imaging of subcellular distributions and plasma membrane insertion.
  • Proximity proteomics to analyze receptor associations.
  • Biochemical analysis of inhibitory receptor association with trafficking adaptors.

Main Results:

  • The five inhibitory receptors exhibited discrete subcellular distributions.
  • CTLA-4 showed the most distinct distribution, associating with lysosomal-derived vesicles and sorting nexin machinery.
  • Divergent trafficking through shared vesicular structures, rather than specific vesicle subtypes, likely drives distinct receptor distributions.

Conclusions:

  • Subcellular localization of inhibitory T cell receptors is distinct and influenced by divergent trafficking pathways.
  • Understanding these trafficking mechanisms is essential for optimizing cancer immunotherapy strategies.
  • This study provides a molecular basis for investigating and targeting T cell inhibitory receptor trafficking.